Prevotella

A Gram-negative, obligate anaerobic genus within the Bacteroidetes phylum that exemplifies context-dependent microbiome effects — beneficial in some settings, pathogenic in others. P. copri is the dominant species in the human gut and a hallmark of plant-rich, fiber-rich diets, while P. intermedia and P. nigrescens are established periodontal pathogens.

Dietary Association and Fiber Metabolism

  • P. copri is strongly enriched in individuals consuming plant-based, high-fiber diets and is the defining taxon of the "Prevotella enterotype" (enterotype 2) [1] [2].
  • Specializes in fermenting complex plant polysaccharides (hemicelluloses, pectins) into short chain fatty acids, particularly propionate and succinate [3].
  • The P. copri-dominated enterotype modifies the relationship between dietary fiber intake and systemic inflammation: fiber's ability to lower C-reactive protein (CRP) is partly mediated through Prevotella-driven SCFA production [2].
  • Abundance declines rapidly on Western-style, low-fiber diets and is nearly absent in some industrialized populations.

Depletion in Disease States

Prevotella depletion is a consistent finding across several autoimmune and neurodegenerative conditions:

  • Multiple sclerosis: decreased in MS patients; negatively associated with Th17 cell frequency. Its loss may reduce anti-inflammatory SCFA signaling to the CNS via the gut brain axis [4].
  • Parkinson's disease: Prevotellaceae consistently reduced in PD patients. Depletion correlates with reduced SCFA production and increased gut permeability, potentially facilitating alpha-synuclein propagation [5].
  • Colorectal cancer: often depleted in CRC cohorts, with its niche occupied by fusobacterium and other pathobionts.
  • Cardiovascular disease: reduced in some CVD cohorts, though less consistently than lachnospiraceae members.

Pathogenic Roles

Despite its commensal reputation, Prevotella has pathobiont potential in specific contexts:

  • Periodontitis: P. intermedia is a classic "orange complex" periodontal pathogen. Oral-to-systemic translocation may contribute to cardiovascular disease risk via chronic inflammation and bacteremia.
  • Rheumatoid arthritis: P. copri is paradoxically enriched in new-onset RA, where it may drive Th17-mediated joint inflammation. This contrasts with its protective role in healthy gut ecology.
  • Endometriosis: Prevotella abundance correlates with constipation and GI symptoms in endometriosis patients [6] [7].
  • Schizophrenia: Prevotella is enriched in first-episode and chronic schizophrenia cohorts and is causally implicated in Mendelian randomization analyses [8] [9].
  • GERD and esophageal disease: Prevotella is enriched in a Type II (Gram-negative, pro-inflammatory) esophageal microbiome signature associated with erosive reflux and Barrett's esophagus [10] [11] [12].
  • Ovarian / gynecologic cancers: Prevotella is altered in ovarian tumor-associated microbiome signatures and is a component of dysbiotic ascites metabolite profiles [13] [14].

Metal Dependencies

  • Some Prevotella species require iron for heme-containing enzymes involved in anaerobic respiration. P. intermedia in particular uses iron acquisition systems for virulence in periodontal niches.
  • The genus is generally sensitive to heavy metal stress — cadmium and lead exposure reduces Prevotella abundance alongside other beneficial anaerobes.
  • Iron supplementation in the gut can paradoxically suppress Prevotella while promoting iron-scavenging enterobacteriaceae.

Key Metabolites

  • Propionate and succinate — primary fermentation end-products from complex carbohydrates.
  • Branched-chain amino acids (BCAAs) — P. copri possesses biosynthetic capacity for BCAAs, which may link to insulin resistance in some metabolic contexts.
  • Bile acid transformation — participates in primary-to-secondary bile acid conversion via bile salt hydrolase activity.

Key Sources

Connections

  • multiple sclerosis — depleted; loss reduces anti-inflammatory SCFA signaling to the CNS
  • parkinsons disease — Prevotellaceae depletion is a hallmark PD microbiome signature
  • rheumatoid arthritis — paradoxically enriched in new-onset RA (Th17 activation)
  • cardiovascular disease — P. intermedia periodontal pathogenesis contributes to systemic inflammation
  • endometriosis — correlated with GI symptoms in endometriosis patients
  • iron — iron-dependent species; sensitive to iron perturbation in the gut lumen
  • dysbiosis — its loss signals fiber-deprived or metal-stressed gut environments
  • inflammation — context-dependent: anti-inflammatory via SCFAs, pro-inflammatory in RA and periodontitis
  • lachnospiraceae — co-depleted in many disease states; complementary fiber fermenters
  • faecalibacterium prausnitzii — metabolic cross-feeding partner in healthy gut ecology

References (24)

  1. Fiona C. Ross, Dhrati Patangia, Ghjuvan Grimaud et al. (2024). The interplay between diet and the gut microbiome: implications for health and disease. Nature Reviews Microbiology
  2. Wenjie Ma, Long H. Nguyen, Mingyang Song et al. (2021). Dietary fiber intake, the gut microbiome, and chronic systemic inflammation in a cohort of adult men. Genome Medicine
  3. Mohammad Tahseen Al Bataineh, Axel Kunstner, Nihar Ranjan Dash et al. (2023). Al Bataineh 2023 — Multi-Omics Analysis of Gut Microbial Dysbiosis, Metabolomics, and Dietary Intake in Type 2 Diabetes. Scientific Reports. doi:10.1038/s41598-023-45066-7
  4. Matteo Bronzini, Alessandro Maglione, Rachele Rosso et al. (2023). Feeding the gut microbiome: impact on multiple sclerosis. Frontiers in Immunology. doi:10.3389/fimmu.2023.1176016
  5. ★Karen Pendergrass (2025). Microbial Metallomics and Parkinson's Disease: A Unified Metal-Driven Framework Linking Ferroptosis, Dysbiosis, and alpha-Synuclein Pathology. Conference Presentation. doi:10.5281/zenodo.17830083
  6. Svensson A, Brunkwall L, Roth B et al. (2021). Associations Between Endometriosis and Gut Microbiota. Reproductive Sciences. doi:10.1007/s43032-021-00506-5
  7. Perez-Prieto I, Vargas E, Salas-Espejo E et al. (2024). Gut microbiome in endometriosis: a cohort study on 1000 individuals. BMC Medicine. doi:10.1186/s12916-024-03503-y
  8. Keer Zhou, Ancha Baranova, Hongbao Cao et al. (2024). Zhou 2024 — Gut Microbiome and Schizophrenia: Insights from Two-Sample Mendelian Randomization. Schizophrenia (Nature Partner Journal). doi:10.1038/s41537-024-00497-7
  9. Dinan TG, Borre YE, Cryan JF (2014). Genomics of Schizophrenia: Time to Consider the Gut Microbiome?. Molecular Psychiatry. doi:10.1038/mp.2014.93
  10. Alageel AA, Alomran DA, Alharbi HB et al. (2025). Alageel 2025 — Examining the Microbiome Composition in Patients with Gastroesophageal Reflux Disease: A Systematic Review. TPM (The Primary Care Companion for CNS Disorders)
  11. Deshpande NP, Riordan SM, Castano-Rodriguez N et al. (2018). Deshpande 2018 — Esophageal Microbiome Signatures and Host Genetics. Microbiome. doi:10.1186/s40168-018-0611-4
  12. Park (2020). Park 2020 — NERD Treatment and Esophageal Microbiome. Scientific Reports. doi:10.1038/s41598-020-72082-8
  13. Gong W, Jin G, Bao Y et al. (2025). Characteristics and potential diagnostic value of gut microbiota in ovarian tumor patients. Scientific Reports. doi:10.1038/s41598-025-99912-x
  14. Shutian Deng, Woojin Kim, Kai Cheng et al. (2025). Deng 2025 — Identification and Impact of Microbiota-Derived Metabolites in Ascites of Ovarian and Gastrointestinal Cancer. Cancer and Metabolism. doi:10.1186/s40170-025-00391-5
  15. Adriel Latorre-Pérez, Marta Hernández, Jose Ramón Iglesias et al. (2021). Latorre-Pérez 2021 — The Spanish Gut Microbiome Reveals Links Between Microorganisms and Mediterranean Diet. Scientific Reports. doi:10.1038/s41598-021-01002-1
  16. Qian Yang, Yaping Wang, Xinyi Wei et al. (2020). Yang 2020 — Vaginal Microbiome Alterations in HPV16 Infection by Shotgun Metagenomics. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2020.00286
  17. Ata B, Yildiz S, Turkgeldi E et al. (2019). The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls. Scientific Reports. doi:10.1038/s41598-019-39700-6
  18. Zhao H, Yuan L, Zhu D et al. (2022). Alterations and Mechanism of Gut Microbiota in Graves' Disease and Hashimoto's Thyroiditis. Polish Journal of Microbiology. doi:10.33073/pjm-2022-016
  19. Capuco A, Urits I, Hasoon J et al. (2020). Current Perspectives on Gut Microbiome Dysbiosis and Depression. Advances in Therapy. doi:10.1007/s12325-020-01272-7
  20. Tiffany L Weir, Daniel K Manter, Amy M Sheflin et al. (2013). Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults. PLoS ONE. doi:10.1371/journal.pone.0070803
  21. Yan F, Xia L, Xu L et al. (2022). A Comparative Study to Determine the Association of Gut Microbiome with Schizophrenia in Zhejiang, China. BMC Psychiatry. doi:10.1186/s12888-022-04328-w
  22. Qiang Geng, Shaofeng Chen, Yuan Sun et al. (2021). Geng 2021 — Gut Microbiota Diversity and Functional Erectile Dysfunction. Research Square (preprint). doi:10.21203/rs.3.rs-454949/v1
  23. Yuanzhao Xu, Lingyue An, Jiling Xie et al. (2026). Xu 2026 — The Gut-Prostate Axis in Benign Prostatic Hyperplasia: Systematic Review of Microbial Dysbiosis and Pathogenic Mechanisms. BMC Urology. doi:10.1186/s12894-025-02003-2
  24. Ismail MA, Althiyabi HA, Alotaibi NM et al. (2025). Understanding the Mechanisms Underlying Gastroesophageal Reflux Disease (GERD) Development: A Systematic Review. TPM

Related Articles